Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
Carolyn Y. Ho(Brigham and Women's Hospital), Eugene Braunwald(Mass General Brigham), Charles E. Canter(St. Louis Children's Hospital), Anna Axelsson Raja(Copenhagen University Hospital), Christine E. Seidman(Harvard University), Edmundo Arteaga(Universidade de São Paulo), Kristin M. Burns(National Heart Lung and Blood Institute), Ivan Wilmot(Cincinnati Children's Hospital Medical Center), John J.V. McMurray(University of Glasgow), Gregory D. Lewis(Brigham and Women's Hospital), Joseph W. Rossano(Children's Hospital of Philadelphia), Alexandre C. Pereira(University of Washington), E. John Orav(Brigham and Women's Hospital), Anjali Owens(University of Pennsylvania), Amit R. Patel(University of Virginia), E. Kevin Hall(Northwestern University), Jonathan H. Soslow(Vanderbilt University Medical Center), Luciana Sacilotto(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Philip T. Thrush(Lurie Children's Hospital), Henning Bundgaard(Copenhagen University Hospital), Neal K. Lakdawala(Brigham and Women's Hospital), Calum A. MacRae(Brigham and Women's Hospital), Matthew T. Wheeler(Stanford University), Jose D. Vargas(MedStar Heart & Vascular Institute), Scott D. Solomon(Brigham and Women's Hospital), Kimberly Y. Lin(Children's Hospital of Philadelphia), Lee Benson(Hospital for Sick Children), Kenneth Zahka(Cleveland Clinic), Jason R. Becker(University of Pittsburgh), Matthew R.G. Taylor(University of Colorado Anschutz Medical Campus), Luisa Mestroni(University of Colorado Anschutz Medical Campus), Elfriede Pahl(Northwestern University), Harry M. Lever(Cleveland Clinic), Allison L. Cirino(University of Campania "Luigi Vanvitelli"), Renée Margossian(Boston Children's Museum), Sharlene M. Day(University of Pennsylvania), Lubna Choudhury(Northwestern University), Richard G. Bach(Washington University in St. Louis), Mark W. Russell(Andover Eye Associates), José Eduardo Krieger(Howard Hughes Medical Institute), Akshay S. Desai(British Heart Foundation), Steven D. Colan(Boston Children's Hospital), Murilo O. Antunes(Universidade de São Paulo), Anne M. Murphy(Johns Hopkins University)
Cited by 132
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k